JP2022502431A5 - - Google Patents

Info

Publication number
JP2022502431A5
JP2022502431A5 JP2021517292A JP2021517292A JP2022502431A5 JP 2022502431 A5 JP2022502431 A5 JP 2022502431A5 JP 2021517292 A JP2021517292 A JP 2021517292A JP 2021517292 A JP2021517292 A JP 2021517292A JP 2022502431 A5 JP2022502431 A5 JP 2022502431A5
Authority
JP
Japan
Prior art keywords
integer
formula
alkyl
ch2ch2o
cycloalkanediyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021517292A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022502431A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/001114 external-priority patent/WO2020065408A1/en
Publication of JP2022502431A publication Critical patent/JP2022502431A/ja
Publication of JP2022502431A5 publication Critical patent/JP2022502431A5/ja
Priority to JP2024106489A priority Critical patent/JP7830555B2/ja
Pending legal-status Critical Current

Links

JP2021517292A 2018-09-27 2019-09-27 スルホマレイミドに基づくリンカーおよび対応する複合体 Pending JP2022502431A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024106489A JP7830555B2 (ja) 2018-09-27 2024-07-01 スルホマレイミドに基づくリンカーおよび対応する複合体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18306270 2018-09-27
EP18306270.2 2018-09-27
PCT/IB2019/001114 WO2020065408A1 (en) 2018-09-27 2019-09-27 Sulfomaleimide-based linkers and corresponding conjugates

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024106489A Division JP7830555B2 (ja) 2018-09-27 2024-07-01 スルホマレイミドに基づくリンカーおよび対応する複合体

Publications (2)

Publication Number Publication Date
JP2022502431A JP2022502431A (ja) 2022-01-11
JP2022502431A5 true JP2022502431A5 (enExample) 2022-10-11

Family

ID=63857832

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021517292A Pending JP2022502431A (ja) 2018-09-27 2019-09-27 スルホマレイミドに基づくリンカーおよび対応する複合体
JP2024106489A Active JP7830555B2 (ja) 2018-09-27 2024-07-01 スルホマレイミドに基づくリンカーおよび対応する複合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024106489A Active JP7830555B2 (ja) 2018-09-27 2024-07-01 スルホマレイミドに基づくリンカーおよび対応する複合体

Country Status (11)

Country Link
US (2) US12011485B2 (enExample)
EP (1) EP3856258B1 (enExample)
JP (2) JP2022502431A (enExample)
KR (1) KR102858995B1 (enExample)
CN (1) CN113453724B (enExample)
AU (1) AU2019350536B2 (enExample)
BR (1) BR112021005655A2 (enExample)
CA (1) CA3113378C (enExample)
MX (1) MX2021003295A (enExample)
WO (1) WO2020065408A1 (enExample)
ZA (1) ZA202101990B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201908886D0 (en) * 2019-06-20 2019-08-07 Almac Discovery Ltd Anthracycline derivatives
CN118955614B (zh) * 2022-07-05 2025-12-30 上海药明合联生物技术有限公司 偶联连接子
CN120957756A (zh) * 2023-05-12 2025-11-14 四川科伦博泰生物医药股份有限公司 稠环化合物及其制备方法和用途
CN119751374A (zh) * 2024-12-09 2025-04-04 中国科学院水生生物研究所 高抑菌活性、低生态毒性的异噻唑啉酮类化合物及其制备方法和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127687A (en) * 1976-07-19 1978-11-28 Rohm And Haas Company Prevention of fouling of marine structures such as boat hulls
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
JPH04248881A (ja) 1991-01-25 1992-09-04 Mitsubishi Kasei Corp 顔料分散型水性記録液
JPH04261476A (ja) 1991-02-15 1992-09-17 Mitsubishi Kasei Corp インクジェットプリンター用クリーニング液
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化b−b10
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
TW258789B (enExample) * 1992-09-28 1995-10-01 Rohm & Haas
KR20070110327A (ko) 2005-03-08 2007-11-16 미쓰비시 가가꾸 가부시키가이샤 이방성 색소 필름용 조성물, 이방성 색소 필름 및 편광소자
JP2007025635A (ja) * 2005-06-17 2007-02-01 Fujitsu Hitachi Plasma Display Ltd プラズマディスプレイ装置及びその処理方法
US20060293374A1 (en) 2005-06-24 2006-12-28 Beers Scott A Substituted isothiazolones
CN101397280A (zh) 2008-11-04 2009-04-01 东华大学 反应性异噻唑啉酮类抗菌整理剂的制备方法
DE102012213321A1 (de) 2012-07-30 2014-01-30 Robert Bosch Gmbh Verfahren und Vorrichtung zum Betreiben eines Fahrzeugs
FR3005051A1 (fr) 2013-04-25 2014-10-31 Pf Medicament Derives de la dolastatine 10 et d'auristatines
JP2016524593A (ja) 2013-04-29 2016-08-18 メモリアル スローン−ケタリング キャンサー センター セカンドメッセンジャーのシグナル伝達を変えるための組成物及び方法
WO2014197866A1 (en) * 2013-06-06 2014-12-11 Igenica Biotherapeutics, Inc. Modified antibodies and related compounds, compositions, and methods of use
US10533010B2 (en) 2014-03-27 2020-01-14 Vanderbilt University Substituted indole Mcl-1 inhibitors
CN106459204B (zh) 2014-04-25 2021-02-02 皮埃尔法布雷医药公司 Igf-1r抗体及其作为定位载体用于治疗癌症的用途
MX378281B (es) * 2014-04-25 2025-03-10 Pf Medicament Conjugado farmaco-anticuerpo y su uso para el tratamiento contra el cancer.
MA39909B1 (fr) 2014-04-25 2019-05-31 Pf Medicament Conjugué anticorps de l'igf-1r-médicament et son utilisation pour le traitement du cancer
CN104230916B (zh) 2014-09-30 2020-04-28 上海化学试剂研究所有限公司 一种异噻唑啉酮类化合物及其制备方法和应用
US20190209704A1 (en) 2014-10-20 2019-07-11 Igenica Biotherapeutics, Inc. Novel antibody-drug conjugates and related compounds, compositions and methods of use
DK3233882T3 (da) 2014-12-16 2020-01-27 Kayla Therapeutics Fluorinerede cykliske dinukleotider til cytokininduktion
TWI706958B (zh) 2015-03-10 2020-10-11 美商艾杜諾生物科技公司 活化「干擾素基因刺激因子」依賴性訊息傳導之組合物及方法
EP3307749A4 (en) * 2015-06-15 2019-06-19 Hangzhou Dac Biotech Co., Ltd HYDROPHILIC LINKER FOR CONJUGATION
WO2017051254A1 (en) * 2015-09-25 2017-03-30 Legochem Biosciences, Inc. Compositions and methods related to anti-egfr antibody drug conjugates
US20180369268A1 (en) 2015-12-16 2018-12-27 Aduro Biotech, Inc. Methods for identifying inhibitors of "stimulator of interferon gene"- dependent interferon production
HK1259487A1 (zh) 2016-02-04 2019-11-29 Hangzhou Dac Biotech Co. Ltd. 特定的共轭连接子,特定的免疫共轭物,制造和使用这些共轭物的方法
WO2018100558A2 (en) 2016-12-01 2018-06-07 Takeda Pharmaceutical Company Limited Cyclic dinucleotide

Similar Documents

Publication Publication Date Title
AU2020202853B2 (en) PEGylated drug-linkers for improved Ligand-Drug Conjugate pharmacokinetics
JP7244987B2 (ja) 多剤抗体薬物コンジュゲート
RU2019105549A (ru) Гидрофильные саморазрушающиеся линкеры и их конъюгаты
JP2023520930A (ja) 電荷多様性リンカー
AU2018368520B2 (en) Ligand-drug-conjugates as substrates for selective cleavage by the exopeptidase activity of Cathepsin B
JP2022525704A5 (enExample)
CN111542344A (zh) 包含单分子量聚肌氨酸的配体-药物-缀合物
JP2015524796A5 (ja) 細胞毒性剤と細胞結合受容体との共役体
EA037203B1 (ru) Конъюгаты антитело-лекарственное средство с самостабилизирующимися линкерами
US20130224228A1 (en) Antibody-Drug Conjugates and Related Compounds, Compositions, and Methods
JP2017528418A5 (enExample)
RU2017101662A (ru) Конъюгаты антитела против фолатного рецептора альфа (fra) c лекарственным средством и способы их применения
JP7830555B2 (ja) スルホマレイミドに基づくリンカーおよび対応する複合体
JP2020519610A5 (enExample)
JP2024528719A (ja) コンジュゲート化試薬及びそのコンジュゲート
CN118119409A (zh) 癌的治疗和/或预防用药物组合物
JP2024520853A5 (enExample)
RU2021110933A (ru) Линкеры на основе сульфомалеимида и соответствующие конъюгаты
RU2815199C2 (ru) Линкеры на основе сульфомалеимида и соответствующие конъюгаты
Johannes et al. Protease-sensitive linkers
WO2026051926A1 (zh) 一种基于依喜替康的抗体-药物偶联物及其制备方法和用途
WO2025206033A1 (ja) uPAR結合性HLHペプチド、ペプチド-薬物複合体および組成物
EA046139B1 (ru) Конъюгаты лиганда-лекарственного средства в качестве субстратов для селективного расщепления под действием экзопептидазной активности катепсина b